Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Dec;1(3-4):165-74.
doi: 10.1007/s12178-008-9032-5.

Platelet rich plasma injection grafts for musculoskeletal injuries: a review

Affiliations

Platelet rich plasma injection grafts for musculoskeletal injuries: a review

Steven Sampson et al. Curr Rev Musculoskelet Med. 2008 Dec.

Abstract

In Europe and the United States, there is an increasing prevalence of the use of autologous blood products to facilitate healing in a variety of applications. Recently, we have learned more about specific growth factors, which play a crucial role in the healing process. With that knowledge there is abundant enthusiasm in the application of concentrated platelets, which release a supra-maximal quantity of these growth factors to stimulate recovery in non-healing injuries. For 20 years, the application of autologous PRP has been safely used and documented in many fields including; orthopedics, sports medicine, dentistry, ENT, neurosurgery, ophthalmology, urology, wound healing, cosmetic, cardiothoracic, and maxillofacial surgery. This article introduces the reader to PRP therapy and reviews the current literature on this emerging treatment modality. In summary, PRP provides a promising alternative to surgery by promoting safe and natural healing. However, there are few controlled trials, and mostly anecdotal or case reports. Additionally the sample sizes are frequently small, limiting the generalization of the findings. Recently, there is emerging literature on the beneficial effects of PRP for chronic non-healing tendon injuries including lateral epicondylitis and plantar fasciitis and cartilage degeneration (Mishra and Pavelko, The American Journal of Sports Medicine 10(10):1-5, 2006; Barrett and Erredge, Podiatry Today 17:37-42, 2004). However, as clinical use increases, more controlled studies are needed to further understand this treatment.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Inactive platelets
Fig. 2
Fig. 2
Active platelets
Fig. 3
Fig. 3
GPS III system and centrifuge
Fig. 4
Fig. 4
GPS III system, withdrawing of platelet poor plasma to be discarded
Fig. 5
Fig. 5
GPS III withdrawing of platelet rich plasma for injection/graft
Fig. 6
Fig. 6
Musculoskeletal ultrasound, common extensor tendinosis
Fig. 7
Fig. 7
Ultrasound guided suprapatella bursa injection/graft
Fig. 8
Fig. 8
Ultrasound guided knee MCL injection/graft

References

    1. Mishra A, Pavelko T. Treatment of chronic elbow tendinosis with buffered platelet-rich plasma. Am J Sports Med. 2006;10(10):1–5. - PubMed
    1. Barrett S, Erredge S. Growth factors for chronic plantar fascitis. Podiatry Today. 2004;17:37–42.
    1. Woolf AD, Pfleyer B. Burdon of major musculoskeletal conditions. Bull World Health Organ. 2003;81:646–56. - PMC - PubMed
    1. Anitua M, Sánchez E, Nurden A, Nurden P, Orive G, Andía I. New insights into and novel applications for platelet-rich fibrin therapies. Trends Biotechnol. 2006;24(5):227–34. doi: 10.1016/j.tibtech.2006.02.010. - DOI - PubMed
    1. Praemer AF. Musculoskeletal conditions in the United States. 2. Rosemont: American Academy of Orthopaedic Surgeons; 1999.